Is There a Potential Role for Rapcabtagene Autoleucel in R/R LBCL?

Experts discuss data on a novel form of CAR T-cell therapy, rapcabtagene autoleucel, for the second-line treatment of R/R LBCL with a faster manufacturing process.

Related Videos
Jeffery Zonder, MD
Jeffery Zonder, MD
Abhinav Deol, MD
Veronika Bachanova, MD, PhD
Eunice Wang, MD
Craig Sauter, MD
Lisa A. Carey MD, ScM, FASCO
Patrick I. Borgen, MD
Anees Chagpar, MD, MBA, MPH, FACS, FRCS(C)
Steven J. Chmura, MD, PhD
Related Content